The Pharmacy and Poisons Board (PPB) has put on notice owners and managers of supermarkets, cosmetic shops, online outlets, and other general retailers, warning against the sale of unregistered or ...

The WHO’s 2025 guidelines mark a milestone for the pharmaceutical cold chain. They draw a clear distinction between ...

DGDA pursuing WHO’s ML-3 accreditation since 2016, which recognizes a country’s drug regulatory authority on the global stage ...

The agency’s sweeping rollout and staff challenge underscore rising momentum behind agentic AI: advanced, multiagent systems ...

The POLARIS-1 trial is a global, multicenter, randomized controlled, open-label Phase III study designed to evaluate the ...

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which ...

Pharmaceutical companies are accused of abusing the patent system to keep drug prices high. Patent manipulation can delay the availability of cheaper generic alternatives for life-saving medications.

As the researchers behind Pfizer and Astellas' Padcev and Merck's Keytruda have taken victory laps on the heels of the positive readout of Keynote-905 study—also known as EV-303—terms like ...

A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the harms of opioids. U.S. Bankruptcy Judge Sean Lane gave ...

Weight loss pills could account for 25% of the market share over the long term. The GLP-1 market is expected to grow to $100 billion by 2030. New GLP-1 oral versions could receive FDA approval by the ...